Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

<jats:sec><jats:title>Aim</jats:title><jats:p>To survey UK cellular pathology departments regarding their attitudes and practices relating to release of human tissue from their diagnostic archives for use in clinical trial research.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A 30-item questionnaire was circulated to the National Cancer Research Institute’s Cellular Molecular Pathology initiative and Confederation of Cancer Biobanks mailing lists. Responses were collected over a 10-month period from November 2016 to August 2017.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>38 departments responded to the survey, the majority of which regularly receive requests for tissue for research purposes. Most requests come from academia and financial support to facilitate tissue release comes from a variety of sources. A range of practices were reported in relation to selection of the most appropriate sample to release, consent checking, costing and governance frameworks.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>This survey demonstrates wide variation in practice across the UK and identifies barriers to release of human tissue for clinical trial research. Until we can overcome these obstacles, patient samples will remain inaccessible to research. Therefore, this study highlights the urgent need for clear and coordinated national guidance on this issue.</jats:p></jats:sec>

Original publication

DOI

10.1136/jclinpath-2018-205476

Type

Journal article

Journal

Journal of Clinical Pathology

Publisher

BMJ

Publication Date

01/2019

Volume

72

Pages

52 - 57